[HTML][HTML] High-content CRISPR screening

C Bock, P Datlinger, F Chardon, MA Coelho… - Nature Reviews …, 2022 - nature.com
CRISPR screens are a powerful source of biological discovery, enabling the unbiased
interrogation of gene function in a wide range of applications and species. In pooled …

[HTML][HTML] CRISPR in cancer biology and therapy

A Katti, BJ Diaz, CM Caragine, NE Sanjana… - Nature Reviews …, 2022 - nature.com
Over the past decade, CRISPR has become as much a verb as it is an acronym,
transforming biomedical research and providing entirely new approaches for dissecting all …

Therapeutic cancer vaccines

M Saxena, SH van der Burg, CJM Melief… - Nature Reviews …, 2021 - nature.com
Therapeutic cancer vaccines have undergone a resurgence in the past decade. A better
understanding of the breadth of tumour-associated antigens, the native immune response …

Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-α

L Wu, Y Jin, X Zhao, K Tang, Y Zhao, L Tong, X Yu… - Cell Metabolism, 2023 - cell.com
Metabolic reprogramming toward glycolysis is a hallmark of cancer malignancy. The
molecular mechanisms by which the tumor glycolysis pathway promotes immune evasion …

KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements

SM Zhang, WL Cai, X Liu, D Thakral, J Luo, LH Chan… - Nature, 2021 - nature.com
Tumours use various strategies to evade immune surveillance,. Immunotherapies targeting
tumour immune evasion such as immune checkpoint blockade have shown considerable …

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

J Dubrot, PP Du, SK Lane-Reticker, EA Kessler… - Nature …, 2022 - nature.com
The immune system can eliminate tumors, but checkpoints enable immune escape. Here,
we identify immune evasion mechanisms using genome-scale in vivo CRISPR screens …

Targeting the epigenetic regulation of antitumour immunity

SJ Hogg, PA Beavis, MA Dawson… - Nature reviews Drug …, 2020 - nature.com
Dysregulation of the epigenome drives aberrant transcriptional programmes that promote
cancer onset and progression. Although defective gene regulation often affects oncogenic …

[HTML][HTML] Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

Z Zhang, ZX Wang, YX Chen, HX Wu, L Yin, Q Zhao… - Genome Medicine, 2022 - Springer
Background Although immune checkpoint inhibitor (ICI) is regarded as a breakthrough in
cancer therapy, only a limited fraction of patients benefit from it. Cancer stemness can be the …

Functional genomic landscape of cancer-intrinsic evasion of killing by T cells

KA Lawson, CM Sousa, X Zhang, E Kim, R Akthar… - Nature, 2020 - nature.com
The genetic circuits that allow cancer cells to evade destruction by the host immune system
remain poorly understood,–. Here, to identify a phenotypically robust core set of genes and …

[HTML][HTML] Large-scale public data reuse to model immunotherapy response and resistance

J Fu, K Li, W Zhang, C Wan, J Zhang, P Jiang, XS Liu - Genome medicine, 2020 - Springer
Despite growing numbers of immune checkpoint blockade (ICB) trials with available omics
data, it remains challenging to evaluate the robustness of ICB response and immune …